Glenmark Secures USFDA Nod for Progesterone Vaginal Inserts, Targets USD 59 Million US Market
New Delhi: Glenmark Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Progesterone Vaginal Inserts, 100 mg, which are therapeutically and bioequivalent to…